Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current Pandemic scenario, all articles related to Coronavirus will be processed on a quick track basis, to ensure timely review and publication of much needed research

Contents

Current Pharmaceutical Design, Volume 8 - Number 26



Pyrazolo-Triazolo-Pyrimidine Derivatives as Adenosine Receptor Antagonists: A Possible Template for Adenosine Receptor Subtypes?

, 8(26): 2299 - 2332

Pier Giovanni Baraldi, Barbara Cacciari, Pier Andrea Borea, Katia Varani, Giorgia Pastorin, Tatiana Da Ros, Mojgan Aghazadeh Tabrizi, Francesca Fruttarolo and Giampiero Spalluto


DOI: 10.2174/1381612023392838





Structure-Activity Relationships of Suramin and Pyridoxal-5-phosphate Derivatives as P2 Receptor Antagonists

, 8(26): 2371 - 2399

Gunter Lambrecht, Kirsten Braun, Susanne Damer, Matthias Ganso, Caren Hildebrandt, Heiko Ullmann, Matthias U. Kassack and Peter Nickel


DOI: 10.2174/1381612023392973




Editor-in-Chief

William A. Banks
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
(USA)

Biography View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32

Advertisement

Covid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog